Martin Capital Partners, LLC holds a diversified book of 72 reported positions worth $272.0M as of Q2 2026 (disclosed Jul 7, 2026, a ~7-day 13F lag). This quarter they opened Public Service Enterprise GP and trimmed Cullen/frost Bankers Inc. Their largest long position is Amgen Inc at 4% of the reported non-option book. Cloning the disclosed picks since 2024 would be +18% (+9.0%/yr). That is a simulation of the disclosed long book, not audited returns.
Growth of $10,000 cloning Martin Capital Partners, LLC's disclosed long 13F book, rebalanced on each filing date (so it reflects each quarter's actual reporting lag, ~7 days for the latest filing, with no look-ahead), total-return basis (dividends reinvested), derived from end-of-day prices. “Their reported book” values the same picks from quarter-end, before they were public. S&P 500 is SPY total return over the same window. Excludes shorts, cash, options and non-13F holdings. Not investment advice.
Top-heavy: diversified book
Share of the disclosed book in its largest positions. A higher top-5 share means a more concentrated, higher-conviction portfolio.
92% mapped to company sectors
+5 sectors below the cut, 12% together
Direct operating-company sectors from our SIC-based security master. ETF/fund and unclassified holdings stay visible separately; this is not ETF look-through exposure.
Estimated $ traded · quarter-end prices (an exit at the prior quarter-end), no cost basis
Other tracked managers holding the same core names as Martin Capital Partners, LLC
| Manager / fund | Shared names | Their $ in those |
|---|---|---|
| Emerald Advisors, LLC | 20 / 72 | $623.8M |
| Independent Investors Inc | 15 / 72 | $383.4M |
| Private Capital Advisors, Inc. | 8 / 72 | $613.2M |
| Harold Davidson & Associates Inc. | 9 / 72 | $122.1M |
| Crescent Sterling, Ltd. | 20 / 72 | $57.0M |
| Saratoga Research & Investment Management | 17 / 72 | $893.7M |
| Diamant Asset Management, Inc. | 20 / 72 | $72.1M |
| Constitution Capital LLC | 15 / 72 | $93.0M |
Ranked by the share of each fund's own book sitting in the names it shares with Martin Capital Partners, LLC: only funds sharing at least a tenth of the book qualify. Index giants, bank custody books and market makers are excluded. They hold everything, so their overlap says nothing.
Bars show each position's share of the portfolio. Click a row for its position history.
| # | Security | Value | Shares | % Port | Last move | History |
|---|---|---|---|---|---|---|
| 1 | Amgen Inc COM | $11.0M | 30.4K | 4.1% | ▲+0.2% Added · +58 sh | |
| 2 | Cullen Frost Bankers Inc COM | $10.8M | 69.9K | 4.0% | ▼−0.1% Reduced · −99 sh | |
| 3 | Johnson & Johnson COM | $10.6M | 41.8K | 3.9% | ▼−0.3% Reduced · −138 sh | |
| 4 | ASML Hldg NV N Y REGISTRY SHS | $10.3M | 5.2K | 3.8% | ▼−21% Reduced · −1K sh | |
| 5 | Cisco Sys Inc COM | $10.1M | 85.9K | 3.7% | ▼−26% Reduced · −30K sh | |
| 6 | Black Hills Corp COM | $9.2M | 123.1K | 3.4% | ▼−0.2% Reduced · −225 sh | |
| 7 | Cme Group Inc COM | $8.9M | 40.1K | 3.3% | ▲+27% Added · +9K sh | |
| 8 | Texas Instrs Inc COM | $8.3M | 28.0K | 3.1% | ▼−26% Reduced · −10K sh | |
| 9 | Chevron Corporation COM | $8.2M | 49.6K | 3.0% | ▼−0.3% Reduced · −179 sh | |
| 10 | JPMorgan Chase & Co COM | $7.8M | 23.7K | 2.8% | ▲+1.0% Added · +231 sh | |
| 11 | Microsoft Corp COM | $7.6M | 20.4K | 2.8% | ▲+1.6% Added · +331 sh | |
| 12 | General Dynamics Corp COM | $7.5M | 21.1K | 2.8% | ▼−0.7% Reduced · −145 sh | |
| 13 | Procter & Gamble Co COM | $7.4M | 50.6K | 2.7% | ▲+38% Added · +14K sh | |
| 14 | Union Pac Corp COM | $7.0M | 25.8K | 2.6% | ▼−0.4% Reduced · −108 sh | |
| 15 | Reinsurance Group Amer Inc COM NEW | $6.9M | 32.6K | 2.5% | ▲+13% Added · +4K sh | |
| 16 | Realty Income Corp COM | $6.7M | 107.5K | 2.4% | ▼−0.3% Reduced · −283 sh | |
| 17 | Unilever PLC SPON ADR NEW | $6.4M | 106.8K | 2.4% | ▲+1.3% Added · +1K sh | |
| 18 | Price T Rowe Group Inc COM | $6.4M | 56.1K | 2.3% | ▲+1.8% Added · +983 sh | |
| 19 | Coca-Cola Femsa SAB De CV SPONS ADS REP | $6.1M | 57.0K | 2.2% | ▼~0% Reduced · −13 sh | |
| 20 | Novo-Nordisk A S ADR | $5.8M | 120.3K | 2.1% | ▲+2.6% Added · +3K sh | |
| 21 | Henry Jack & Assoc Inc COM | $5.6M | 40.9K | 2.1% | ▲+684% Added · +36K sh | |
| 22 | Portland Gen Elec Co COM NEW | $5.6M | 108.5K | 2.1% | ▼−0.3% Reduced · −273 sh | |
| 23 | Medtronic PLC SHS | $5.5M | 70.4K | 2.0% | ▲+1.4% Added · +998 sh | |
| 24 | Public SVC Enterprise Group COM | $5.5M | 67.8K | 2.0% | ▲New New position | |
| 25 | Pepsico Inc COM | $5.5M | 40.5K | 2.0% | ▼−0.1% Reduced · −56 sh | |
| 26 | Devon Energy Corp New COM | $5.5M | 132.2K | 2.0% | ▼−0.1% Reduced · −184 sh | |
| 27 | Entergy Corp New COM | $5.5M | 47.6K | 2.0% | ▼−0.5% Reduced · −243 sh | |
| 28 | SPDR Series Trust ST SHOR CORP ETF | $5.3M | 176.9K | 2.0% | ▼−3.7% Reduced · −7K sh | |
| 29 | Paychex Inc COM | $5.3M | 53.7K | 1.9% | ▲+667% Added · +47K sh | |
| 30 | Totalenergies SE ACT | $5.0M | 64.1K | 1.8% | ▼−0.6% Reduced · −360 sh | |
| 31 | Verizon Communications Inc COM | $4.8M | 113.0K | 1.8% | ▼−3.7% Reduced · −4K sh | |
| 32 | Ishares TR ISHS 1-5YR INVS | $4.7M | 88.8K | 1.7% | ▼−2.3% Reduced · −2K sh | |
| 33 | Pfizer Inc COM | $4.5M | 188.6K | 1.7% | ▼−0.2% Reduced · −322 sh | |
| 34 | Clorox Co Del COM | $4.4M | 45.9K | 1.6% | ▼−0.2% Reduced · −78 sh | |
| 35 | Home Depot Inc COM | $4.3M | 12.1K | 1.6% | ▲+3.3% Added · +385 sh | |
| 36 | Phillips 66 COM | $4.0M | 23.7K | 1.5% | ▼−30% Reduced · −10K sh | |
| 37 | Ishares TR 1 3 YR TREAS BD | $3.7M | 45.0K | 1.4% | ▼−2.8% Reduced · −1K sh | |
| 38 | McCormick & Co Inc COM NON VTG | $3.5M | 69.3K | 1.3% | ▼−46% Reduced · −58K sh | |
| 39 | Ishares TR 0-5 YR TIPS ETF | $3.3M | 32.2K | 1.2% | ▼−2.9% Reduced · −948 sh | |
| 40 | Nike Inc CL B | $3.2M | 78.1K | 1.2% | ▲+5.0% Added · +4K sh | |
| 41 | Principal Financial Group In COM | $1.2M | 10.7K | 0.4% | ▼−0.3% Reduced · −33 sh | |
| 42 | Ishares TR 3 7 YR TREAS BD | $1.1M | 9.3K | 0.4% | ▼−3.7% Reduced · −359 sh | |
| 43 | Quest Diagnostics Inc COM | $1.0M | 4.9K | 0.4% | ▼−0.5% Reduced · −25 sh | |
| 44 | MSC Indl Direct Inc CL A | $917K | 7.7K | 0.3% | ▼−7.7% Reduced · −639 sh | |
| 45 | Apple Inc COM | $826K | 2.9K | 0.3% | ▼−11% Reduced · −342 sh | |
| 46 | Cencora Inc COM | $822K | 2.9K | 0.3% | ▼−2.3% Reduced · −68 sh | |
| 47 | Lincoln Elec Hldgs Inc COM | $648K | 2.4K | 0.2% | ▼−0.2% Reduced · −4 sh | |
| 48 | Schwab Strategic TR US DIVIDEND EQ | $637K | 20.1K | 0.2% | ▼−6.4% Reduced · −1K sh | |
| 49 | SPDR Series Trust ST STR SP DIV | $599K | 3.9K | 0.2% | ▼−6.2% Reduced · −259 sh | |
| 50 | Ingredion Inc COM | $487K | 5.1K | 0.2% | ▲+0.2% Added · +11 sh |
This fund page is the Follow view. The Build view lets your agent pull holdings, quarter changes, overlap, and source filings through API or MCP.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/funds/1731216/holdings"
Use Arkolith to show Martin Capital Partners, LLC's latest holdings, largest changes, and filing provenance.
As-of date vs the date the SEC received each filing
Reported 13F total per quarter. Raw filing totals can include option notional.
| Quarter | As of | Filed | Lag | Positions | Value | Form |
|---|---|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | Jul 7, 2026 | 7d | 72 | $272.0M | 13F-HR |
| Q1 2026 | Mar 31, 2026 | Apr 7, 2026 | 7d | 68 | $269.1M | 13F-HR |
| Q4 2025 | Dec 31, 2025 | Jan 6, 2026 | 6d | 70 | $265.8M | 13F-HR |
| Q3 2025 | Sep 30, 2025 | Oct 6, 2025 | 6d | 70 | $257.8M | 13F-HR |
| Q2 2025 | Jun 30, 2025 | Jul 8, 2025 | 8d | 75 | $255.1M | 13F-HR |
| Q1 2025 | Mar 31, 2025 | Apr 15, 2025 | 15d | 58 | $83.6M | 13F-HR |
| Q4 2024 | Dec 31, 2024 | Jan 27, 2025 | 27d | 58 | $84.3M | 13F-HR |
| Q3 2024 | Sep 30, 2024 | Oct 15, 2024 | 15d | 69 | $202.4M | 13F-HR |
Holdings from SEC EDGAR 13F-HR filings, updated quarterly, filed up to 45 days after quarter-end. Public domain. Book totals and portfolio weights cover reported non-option positions, which can include notes and warrants. Disclosed put/call options are listed separately and excluded from those totals. The performance line is a simulation of the disclosed long book, not an audited return.